Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new era

doi:10.3748/wjg.v30.i8.806

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1210)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

WORD

HTML

851

Figures (1-1)

Sum=1024

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=120

Feb 28, 2024 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Gastroenterol. Feb 28, 2024; 30(8): 806-810
Published online Feb 28, 2024. doi: 10.3748/wjg.v30.i8.806

Open in New Tab Full Size Figure Download Figure

Figure 1 Unanswered questions about adjuvant therapy for patients with hepatocellular carcinoma following potentially curative resection or local ablation. Questions appear within the pie, and evidence-based responses are written around it. AIT: Adoptive immunotherapy; HAIC: Hepatic arterial infusion chemotherapy; ICI: Immune checkpoint inhibitor; RFS: Recurrence-free survival; TACE: Transarterial chemoembolization; Vp1: Segmental portal vein invasion; Vp2: Right anterior or posterior portal vein invasion.

Citation: Zhong JH. Adjuvant therapy for hepatocellular carcinoma: Dilemmas at the start of a new era. World J Gastroenterol 2024; 30(8): 806-810
URL: https://www.wjgnet.com/1007-9327/full/v30/i8/806.htm
DOI: https://dx.doi.org/10.3748/wjg.v30.i8.806